medigraphic.com
ISSN 2500-7106 (Electronic)
ISSN 0123-2576 (Print)
Medicina & Laboratorio

2020, Number 4

Next >>

Medicina & Laboratorio 2020; 24 (4)

The role of the clinical laboratories in the patient with hemophilia

Guevara-Arismendy NM

Language: Spanish
References: 5
Page: 271-272
PDF size: 133.28 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Delavenne X, Dargaud Y. Pharmacokinetics for haemophilia treaters: Meaning of PK parameters, interpretation pitfalls, and use in the clinic. Thromb Res 2020;192:52-60. https://doi.org/10.1016/j.thromres.2020.05.005.

  2. Iorio A. Using pharmacokinetics to individualize hemophilia therapy. Hematology 2017;2017:595-604. https:// doi.org/10.1182/asheducation-2017.1.595.

  3. Gringeri A, Doralt J, Valentino LA, Crea R, Reininger AJ. An innovative outcome-based care and procurement model of hemophilia management. Expert Rev Pharmacoecon Outcomes Res 2016;16:337-345. https://doi.org /10.1080/14737167.2016.1178066.

  4. Magnette A, Chatelain M, Chatelain B, Ten Cate H, Mullier F. Pre-analytical issues in the haemostasis laboratory: guidance for the clinical laboratories. Thromb J 2016;14:49. https://doi.org/10.1186/s12959-016-0123-z.

  5. Gosselin RC, Marlar RA. Preanalytical variables in coagulation testing: Setting the stage for accurate results. Semin Thromb Hemost 2019;45:433-448. https://doi.org/10.1055/s-0039-1692700.




2020     |     www.medigraphic.com